Global Contraceptive Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: August 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Contraceptive Market was valued at $32.5 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 5.8% CAGR, to an estimated market size of $43.1 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global contraceptive market encompasses pharmaceutical drugs (oral pills, injectables, topical patches) and medical devices (condoms, IUDs, subdermal implants, vaginal rings, and diaphragms) designed to prevent unintended pregnancy and reduce the transmission of sexually transmitted diseases (STDs). The scope includes both hormonal and non-hormonal modern methods but excludes permanent surgical sterilization procedures.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Contraceptive Market in the period 2025-30:
- Increasing adoption of Long-Acting Reversible Contraceptives (LARC), such as IUDs and implants, due to their high clinical efficacy and low maintenance requirements.
- The rapid rise of telecontraception and digital health platforms that provide virtual consultations and direct-to-door delivery of birth control products.
- Expansion of over-the-counter (OTC) accessibility for oral contraceptive pills, reducing traditional prescription barriers and increasing user autonomy.
- Rising prevalence of sexually transmitted diseases (STDs) globally, which continues to drive the demand for barrier methods like male and female condoms.
- Aggressive government-led population control initiatives and international family planning programs targeting high unmet needs in developing regions.
- Growing investment in FemTech and the development of innovative non-hormonal solutions to address user concerns regarding hormonal side effects.
- Heightened focus on male contraceptives and the development of new formulations to encourage shared responsibility in reproductive health.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- LAMEA
Segments
- Contraceptive Drugs
- Contraceptive Devices